Cite
HARVARD Citation
Chan, J. et al. (2020). Real‐world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate‐resistant prostate cancer: The Singapore experience. Asia-Pacific journal of clinical oncology. 16 (1), pp. 75-79. [Online].